Novasep: Press Releases
Cerenis Therapeutics and Novasep Awarded €10.7 Million Funding from the French Government for the Development of CER-001, an HDL Mimetic
Cerenis Therapeutics (Cerenis), a biopharmaceutical company developing novel high-density lipoprotein (HDL) therapies to treat cardiovascular and other metabolic diseases, and Groupe...
Novasep and instrAction Enter into Worldwide Strategic Alliance
Novasep, a leading supplier of manufacturing solutions to the life science industries, and instrAction, a manufacturer of innovative chromatographic stationary phases for API...
Novasep Launches Brand New Website
We would like to invite you to discover our new website, which has just launched: www.novasep.com. Here you will find some exciting changes and improvements: Easy to navigate with...
Novasep Releases New White Paper: Carbonylation Using Carbon Monoxide
Novasep is a leading partner for the life science industries, developing, marketing and operating innovative technologies to produce synthetic molecules and biomolecules from lab to...
Novasep Announces Successful Validation of a cGMP Manufacturing Process for the Proveblue API
Novasep, a leading supplier of manufacturing solutions to the life sciences industries, and Provepharm, a start-up specialised in the development of pharmaceutical applications for...
Novasep Gains SafeBridge® 'Potent Compound Safety Certification' for its Le Mans Facility
Novasep is pleased to announce that its site in Le Mans, France, specialised in the development and manufacturing of highly potent active pharmaceutical ingredients (HPAIs), has received...
Antoine Baule Appointed as President of Novasep Process
Novasep welcomes Antoine Baule as the president of its subsidiary company, Novasep Process. He replaces Erwin Herren who was Novasep Process' interim president since January 2008. Erwin...
Novasep Acquires Bioprocess Development Specialist And Contract Manufacturer Henogen
Novasep, a leading producer of active pharmaceutical ingredients (APIs) and purification technologies for the life science industries, announced today the acquisition of Henogen, a...
Novasep Names New Sales Director
Novasep has welcomed Kevin Daley as sales director of Finorga and Séripharm. He will be based in Chasse-sur-Rhône, France. With a career spanning more than 25 years in the...
Novasep Has Extended its Custom Chiral Separation Capabilities to Offer Optimized and Efficient Purification Solutions to its Life Science Customers
Novasep, a global leader in advanced separation technologies, has recently added a state-of-the-art cGMP pilot-scale continuous chromatography unit in its Chasse sur Rhône (France) facility....
Novasep to Introduce New SiusTM Cassettes, Pre-Sanitized Single-Use Product at BioProcess International Conference 2008
Sius™ is a breakthrough single-use product for Tangential-Flow-Filtration (TFF) applications in the downstream processing of biopharmaceuticals. Sius provides economic savings, as well as...
Twitter